Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

FDA advisory committee recommends approval of drug combination for hepatitis C

May 6, 1998

Sagami presents new anti-H. pylori agents

May 6, 1998

YJA-20379, an H+/K+-ATPase inhibitor that inhibits H. pylori

May 1, 1998

Corvas/Schering-Plough HCV protease collaboration extended

May 1, 1998

Gastric prokinetic effects and safety of EM-574 in healthy subjects

April 30, 1998

Gastric prokinetic/antiemetic agents from Dainippon

April 28, 1998

Clinical trials of reformulated H-BIG completed

April 28, 1998

TAK-044 and its effects on liver injury and portal hypertension in rats

April 28, 1998

FDA advisory committee will meet to discuss Avakine NDA

April 28, 1998

Roberts acquires Pentasa marketing rights from HMR

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...